DarioHealth Corp. 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by DarioHealth Corp. (Nasdaq: DRIO) on April 18, 2025. The filing discloses significant changes to the company's executive leadership, specifically the departure of the Chief Financial Officer and the appointment of a successor, effective May 15, 2025.
Key Financial Metrics
This filing does not contain revenue, profit, cash flow, margin, debt, or liquidity metrics. The document focuses exclusively on executive compensation and separation terms.
Material Changes
- Departure: Zvi Ben-David resigned as Chief Financial Officer, Treasurer, and Secretary for personal reasons, with no disagreement regarding company operations.
- Appointment: Chen Franco-Yehuda was appointed as the new Chief Financial Officer, Treasurer, and Secretary. She previously served as CFO of Pluri Inc. and holds a CPA in Israel.
- Compensation Structure (New CFO):
- Monthly salary: NIS 82,000 (approx. $22,245).
- Target bonus: Up to six times base salary, subject to milestones.
- Equity: 500,000 restricted shares vesting over three years (one-third on April 27, 2026; remainder quarterly).
- Severance: 90 days minimum plus Israeli statutory severance if terminated at-will; full acceleration of unvested awards in a change of control.
- Separation Terms (Former CFO):
- Mr. Ben-David will join the advisory board.
- Reduced monthly payments in lieu of notice and vacation: NIS 52,500 (approx. $14,266) from July 1, 2025, to December 31, 2025.
- Reduced monthly payments: NIS 47,775 (approx. $12,982) from January 1, 2026, to October 31, 2027.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future business performance. The primary risk disclosed relates to the transition of financial leadership and the associated contractual obligations for severance and new executive compensation.
Investor Verification Checklist
- Verify the exact vesting schedule and performance milestones for the 500,000 restricted shares granted to Chen Franco-Yehuda.
- Confirm the total cash outflow obligation for the former CFO's separation agreement through October 2027.
- Review the attached Exhibits 10.1 and 10.2 for full legal terms of the employment and separation agreements.
- Monitor subsequent filings for the official transition of duties on May 15, 2025.